Assignee
MEMO THERAPEUTICS AG
CH·3 granted patents·2 pending applications·0 citations·filing 2015–2023
Top patents by PatentIndex Score
5 records- 0166US11976276B2Method for recovering two or more genes, or gene products, encoding an immunoreceptorMEMO THERAPEUTICS AG·Filed 2021·Granted May 7, 2024·0 cites·18 claims
- 0264US2024228590A9Anti-bk virus antibody moleculesMEMO THERAPEUTICS AG·Filed 2023·Application pending·0 cites
- 0362US11919943B2Anti-BK virus antibody moleculesMEMO THERAPEUTICS AG·Filed 2022·Granted Mar 5, 2024·0 cites·16 claims
- 0448US2023009582A1Anti-siglec-9 antibody moleculesMEMO THERAPEUTICS AG·Filed 2020·Application pending·0 cites
- 0543US11312952B2Method for recovering two or more genes, or gene products, encoding an immunoreceptorMEMO THERAPEUTICS AG·Filed 2015·Granted Apr 26, 2022·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when MEMO THERAPEUTICS AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →